tiprankstipranks
Trending News
More News >

Apellis price target lowered to $20 from $30 at Mizuho

Mizuho lowered the firm’s price target on Apellis (APLS) to $20 from $30 and keeps a Neutral rating on the shares. The firm reduced its view for the company’s lead asset Syfovre for geographic atrophy. Due to several factors, including lingering safety questions, potentially stalling growth for the class, and the negative impact from recent changes to patient co-pay assistance programs, Mizuho now envisions “persistent challenges” for Syfovre’s uptake.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue